SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 651.80-0.3%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotechwantabe who wrote (3236)2/4/2022 7:49:23 PM
From: BioBait  Read Replies (2) of 3557
 
2021 guesstimate

Dupi 4b +50% +2b
Eylea 8b +10% .8b
Cov2 US +3b ROW +3b (possibly more but being conservative)
Other 1b +20% +.2b. (Maybe libtayo does better?)

On 2020 13b +9b = 22b ~70% product revenue increase

P/E ratio of ~20%. Will not hold for long.

__——_————_———

2022 guesstimate

Dupi 6.2 +33% +2b
Eylea 9.4 +15% +1.4b
Cov2 US +0
Other 1.4 +20% +.3b (Maybe libtayo does better?)

On 2021 24.5 -7.5b COV2 + 3.7 = 20.7 ~22% product revenue increase
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News